Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,193 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07501663Recruiting
Managing nerve damage from chemo in GI cancer survivors
This study tests different integrative approaches (like acupuncture or supplements) to help GI cancer survivors manage nerve damage from chemotherapy. You may be able to join if you have ongoing numbness and tingling from chemo.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT07501858Recruiting
H. pylori and insulin resistance in metabolic syndrome
This study looks at whether a common stomach infection (H. pylori) affects insulin resistance in people with metabolic syndrome. It uses simple tests like a breath test, stool sample, and blood draw to check if treating the infection could help improve metabolic health.
Novosibirsk, Novosibirsk OblastAges 18–65 - NCT07504796RecruitingPhase 2
Adding ipilimumab to standard melanoma therapy based on ctDNA
This trial tests whether adding a second immunotherapy drug (ipilimumab) to the standard first-line combo of nivolumab and relatlimab improves outcomes for advanced melanoma. It uses a blood test (ctDNA) to decide who gets the extra drug.
New York, New YorkAges 18 years+ - NCT07506109RecruitingPhase 2
Study of sintilimab, ipilimumab, cetuximab, and dabrafenib for advanced colorectal cancer
This trial tests a combination of four drugs for people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07504913Recruiting
Quality of life survey for stomach cancer patients after surgery
This study tests a new questionnaire to measure quality of life in people who had surgery to remove stomach cancer. If you had surgery for stomach cancer between 1 month and 5 years ago and are cancer-free now, your answers can help improve care.
Badalona, BarcelonaAges 18 years+ - NCT07506174Recruiting
Pelvic PNF and trunk training for stroke recovery
This trial tests whether combining pelvic PNF (a therapy that uses specific patterns to improve movement) with trunk training can help people with chronic stroke walk better and improve balance.
Lahore, Punjab ProvinceAges 40–75 - NCT07506720Recruiting
Early biking in bed after spine surgery
This study tests whether a short session of pedaling a special bike while lying in bed, soon after spine surgery, can help you recover faster. It's for people who could walk before surgery and are stable after the operation.
Montreal, QuebecAges 18 years+ - NCT06764836RecruitingPhase 1
IMM2510 + IMM27M for advanced solid tumors
This study tests a combination of two immune-based drugs, IMM2510 and IMM27M, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink or slow the growth of cancer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06763159RecruitingPhase 1
Study of HS-20124 for advanced solid tumors
This study tests a new drug called HS-20124 for people with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the drug is safe and how well it works.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05642182RecruitingPhase 1
Study drug trial for mild to moderate plaque psoriasis
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
Pompano Beach, FloridaAges 18 years+ - NCT05583006Recruiting
Switch from entecavir to tenofovir for chronic hepatitis B
This trial studies switching people with chronic hepatitis B from entecavir (ETV) to tenofovir alafenamide (TAF). It may help if you feel your current entecavir treatment isn’t working well enough or is inconvenient.
Taichung, TaiwanAges 20 years+ - NCT06531928Recruiting
Chest tube removal and anxiety after lung surgery
This study looks at whether the way a chest tube is removed after lung surgery affects how anxious patients feel. If you had keyhole lung surgery with one chest tube, this trial may help understand your experience.
Ankara, KeçiörenAges 18–65 - NCT06766461RecruitingPhase 4
Optimizing antibiotic dosing in ICU patients with septic shock
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
RotterdamAges 18 years+ - NCT06749951Recruiting
Talk therapy for insomnia in heart disease patients
This study tests whether cognitive behavioral therapy (a type of talk therapy focused on changing thoughts and habits) can help people with coronary heart disease who also have trouble sleeping. You will learn skills to improve your sleep and your overall heart health.
Drammen, BuskerudAges 18–75 - NCT06765252Recruiting
How gene differences affect capecitabine side effects
This study looks at how genetic differences in Egyptian people with breast or colorectal cancer might affect the side effects of the chemotherapy drug capecitabine. The goal is to understand why some people have more side effects than others.
Shibīn al Kawm, MenoufiaAges 18 years+ - NCT06765850Recruiting
Melanoma blood marker study
This study looks at small molecules in your blood (called the metabolome) using special tests. Researchers want to see if these molecules change depending on how your melanoma progresses, which may help improve future care.
Dresden, SaxonyAges 18 years+ - NCT06765005RecruitingPhase 1/Phase 2
Study of MG-K10 for Teens with Moderate to Severe Eczema
This study tests a new injectable medication called MG-K10 for teens with moderate to severe eczema that hasn't been well controlled with creams. The goal is to see if it can safely reduce inflammation and improve skin symptoms.
Hangzhou, ZhejiangAges 12–18 - NCT07491744Enrolling by invitation
Stroke and TIA study on heart and blood vessel health
This study looks at the causes of stroke and TIA by doing extra tests on patients admitted to the hospital. It aims to better understand and prevent future heart and blood vessel problems.
Stockholm, Stockholm CountyAges 18 years+ - NCT07491042Recruiting
A study of SGLT2 inhibitors for people on peritoneal dialysis
This study tests whether a type of diabetes medicine called SGLT2 inhibitors (which help lower blood sugar and protect the kidneys) can benefit people who are on chronic peritoneal dialysis. You may be able to join if you are 13 or older, have some urine output, and do not have certain other health issues.
NizwaAges 13 years+ - NCT07492511Recruiting
Ultrasound patterns in kidney and liver after trauma
This trial uses special ultrasound (Doppler) to look at blood flow in the kidneys and liver after a serious injury. It aims to find patterns that could help doctors better understand and treat trauma patients.
BolognaAges 18–65 - NCT07496723Recruiting
Comparing diagnostic methods for appendicitis surgery
This trial looks at whether different ways of diagnosing appendicitis (like CT scans) are accurate. It's for people who already had surgery to remove their appendix and want to help doctors learn more.
Sanliurfa, ŞanlıurfaAges 18 years+ - NCT04513626RecruitingPhase 2
HIV trial testing doravirine plus raltegravir in adults
This Phase 2 trial studies whether switching to a combination of doravirine and raltegravir can safely maintain control of HIV in adults whose virus is already well suppressed. It may help people who are currently on stable HIV treatment and are not resistant to these specific medicines.
Paris, Île-de-France RegionAges 18 years+ - NCT05353348Recruiting
Program to treat mild anemia around heart surgery
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hangzhou, ZhejiangAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,193 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.